Vimarsana
Biggest News Aggregation in the World

Page 45 - Research Head News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Head Today - Breaking & Trending Today

Global Rare Disease Drug Market Size Clinical Trials Insight 2028 - Vimarsana News

Global Rare Disease Drug Market Size Clinical Trials Insight 2028

Rare disease is disorder which affects a small percentage of total population. In last few years, there has been increased interest among pharmaceutical companies for the development of novel orphan drugs against rare diseases.

Global market conditions affected Paytm's IPO: Vijay Shekhar Sharma - Vimarsana News

Global market conditions affected Paytm's IPO: Vijay Shekhar Sharma

Paytm CEO Vijay Shekhar Sharma has said that macro conditions have affected global fintech companies, including Paytm, but the fintech industry will soon bounce back, driven by payments revenue.Speaking at IAMAI's 'India Digital Summit 2022', ...

Paytm's IPO braved stock market when global fintech was drowning - Vimarsana News

Paytm's IPO braved stock market when global fintech was drowning

Paytm made a big bang debut in the stock market

Paytm's IPO braved stock market when global fintech was drowning - Vimarsana News

Paytm's IPO braved stock market when global fintech was drowning

Paytm made a big bang debut in the stock market. The company's $2.5 billion IPO was not just India's largest but also the largest APAC fintech IPO ever and also the second largest fintech IPO of 2021 globally.Overall, Paytm IPO is the 4th ...

Daily Market Commentary - Jan 4, 2022 - Bonanza Portfolio - Vimarsana News

Daily Market Commentary - Jan 4, 2022 - Bonanza Portfolio

Daily Market Commentary for Jan 4, 2022 by Mr Vishal Wagh, Research Head - Bonanza Portfolio.